1 – 10 of 98
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Copy number signatures in cervical samples enable early detection of high-grade serous ovarian carcinoma
2025) SCRM 2025 - the 7th Swedish Cancer Research Meeting(
- Contribution to conference › Poster
-
Mark
High prevalence of FAP+ cancer-associated fibroblasts predicts poor outcome in patients with high-grade serous ovarian cancer with high CD8 T-cell density
(
- Contribution to journal › Article
-
Mark
Human proteome distribution atlas for tissue-specific plasma proteome dynamics
(
- Contribution to journal › Article
-
Mark
Tertiary lymphoid structures in high-grade serous tubo-ovarian carcinoma : anatomical site matters
(
- Contribution to journal › Article
- 2024
-
Mark
An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer
(
- Contribution to journal › Article
-
Mark
Longitudinal molecular profiling elucidates immunometabolism dynamics in breast cancer
(
- Contribution to journal › Article
-
Mark
Molecular patterns of resistance to immune checkpoint blockade in melanoma
(
- Contribution to journal › Article
-
Mark
Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma
(
- Contribution to journal › Article
- 2023
-
Mark
A deep tabular data learning model predicting cisplatin sensitivity identifies BCL2L1 dependency in cancer
(
- Contribution to journal › Article
-
Mark
Breast cancer associated CD169+ macrophages possess broad immunosuppressive functions but enhance antibody secretion by activated B cells
(
- Contribution to journal › Article